Batch 001 - Live Allocation
Next Release: Aug 2026
Demo · Switch Role
Demo mode. In production, this would be authentication-driven. Each role sees only what's relevant to their workflow.
VL
Vivre Labs
Institutional Longevity
- Peptides -
- Single-vial Blends -
- Goals -
- Clinical Reference -
- Guides -
- Integrity -

◇ Compound Reference

Tirzepatide

Dual Agonist · 20mg

Vial size
MechanismGLP-1 / GIP
Educational reference only - not a prescription or dosing recommendation. Some compounds are investigational or used off-label; suitability, dose, and monitoring are determined by your supervising physician. See Informed Consent & Disclaimer.
V-Series Member
$200 USD/vial
À-la-carte: $225 USD/vial · Save 11%
Vials per allocation
Member total (1×)$200
À-la-carte total$225
Flat per-vial pricing. Quantity is allocated and dispensed within your physician-supervised protocol - not a direct sale.
What this is

Larger 20mg vial of Tirzepatide - better per-mg value for sustained weekly maintenance dosing.

Dual Agonist · 20mg per vial · dispensed after a physician review.

◇
Janoshik Verified
HPLC + MS purity, every batch
Independent third-party lab
⬡
COA Per Batch
Lot-level certificates published
Labeled vs actual mg disclosed
⊙
Protocol Reviewed
Used in V-Series clinical stacks
Phase 1 supervision onboarding
Used inV-Series
V-03
Metabolic - Weight & Blood Sugar
Popular · GLP-1 + Lean Mass
V-M2
Metabolic Plus - Advanced Weight Loss
Popular · Next-Gen Metabolic
Tirzepatide ·
◆ Certificate of Analysis · Tirzepatide
JANOSHIK ANALYTICALHPLC + MS · Independent third-party
Batch 001 · lot VL-TRZ-2026-07A

Every 100 units are drawn from one lot and tested once. The certificate below is the one that applies to this batch - when it closes, the next opens with a new lot and a new certificate.

DEMO
Lot · VL-TRZ-2026-05A
99.91%
Labeled
10 mg
Actual (HPLC)
10.68 mg
Method
HPLC + MS
Tested
May 10, 2026
Endotoxin
not tested for this lot
Heavy metals
not tested for this lot
Janoshik AnalyticalPDF pending
▣
Featured In
V-Series Protocols Including Tirzepatide
V-03
Metabolic - Weight & Blood Sugar
Visceral fat reduction with lean mass and dermal preservation
Contains
Tirzepatide (Base Form)Tesamorelin
V-M2
Metabolic Plus - Advanced Weight Loss
Triple-receptor weight reduction with sustained energy
Contains
Retatrutide (Base Form)Tesamorelin
READY TO PROCEED

Start with the Biological Audit

Tirzepatide is verified and lot-tested, dispensed following a Biological Audit. The Audit is complimentary for the Batch 001 cohort.

$200 USD/vial
Tirzepatide · Member rate
VL
Vivre Labs
Institutional Longevity

Clinical optimization through institutional medicine. All protocols verified and lot-tested, MSO-administered, hospital-integrated.

V-Series

Peptides

Metabolic
Repair & Aesthetic
Neurological
Growth & Hormonal
Longevity & Immune
Sexual Health

Navigate

Verification

Legal

DEMO SITE - PRESENTATION PURPOSES ONLY. All protocols verified and lot-tested, dispensed after comprehensive medical evaluation. Compounds sourced from registered cGMP compounding pharmacies. Individual results vary. MSO structures and revenue models are illustrative for partner conversations. Regulatory outcomes reference publicly disclosed FDA processes and are anticipated but not guaranteed.

© 2026 Vivre Labs. All rights reserved.

cGMPLot-TestedDemo

Demonstration prototype - not a live service